Wondering about life expectancy with amyloidosis is completely understandable. The good news is that treatments have improved significantly in recent years, and many people are living longer than ever before. As one MyAmyloidosisTeam member put it: "All of us don't know our life expectancy with this disease. The only thing Show Full Answer
Wondering about life expectancy with amyloidosis is completely understandable. The good news is that treatments have improved significantly in recent years, and many people are living longer than ever before. As one MyAmyloidosisTeam member put it: "All of us don't know our life expectancy with this disease. The only thing we can do is live our lives to the fullest."
Life expectancy depends on several key factors:
- Type of amyloidosis (AL, ATTR, AA, hATTR)
- Which organs are affected — heart involvement tends to have the biggest impact
- Stage at diagnosis — earlier stages are linked to better outcomes
- Access to and response to treatment Here's a general breakdown by type:
AL Amyloidosis
- Median survival has improved from 1.4 years (1980s) to 4.6 years (2010–2019)
- About 1 in 5 people live 10+ years with newer treatments
- Stage 1: ~7.8 years | Stage 2: ~3.4 years | Stage 3: ~14 months | Stage 4: ~5.8 months hATTR Amyloidosis
- Untreated median survival was around 4.7 years
- Newer therapies are helping some people live a decade or more
- Factors like gene mutation type and organ involvement play a big role Cardiac ATTR Amyloidosis
- Stage 1: ~5.8 years | Stage 2: ~3.9 years | Stage 3: ~2 years
AA Amyloidosis
- With early, effective treatment, many people live 10+ years
- Advanced stages can be more limiting, but outcomes are improving with better anti-inflammatory treatments It's really important to remember that these are averages — individual outcomes can vary widely. Speaking with your doctor about your specific type, stage, and treatment plan will give you the most accurate picture of your personal outlook.
May 8
Join
Your Privacy Choices
